Sale of 2,202 shares at $36.69 per share.
Reporting Person Degnan Chris · Officer Title Chief Financial Officer · Transaction Code S
Traded Oct 8, 2026 · Disclosed Oct 9, 2026
Source: SEC Form 4 · 0001437749-26-032421 · filed 2026-10-09 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "UroGen Pharma Ltd. (URGN)." Disclosed 2026-10-09. https://desqlong.com/cards/0001437749-26-032421-2 (retrieved 2026-10-10).